No additional AE; patient who was administered improperly stored VARIVAX following a TE; This spontaneous report was received from an other reporter referring to a patient of unknown age and gender. The patient’s medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 28-JAN-2025, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot # Y011019, expiration date: 18-JUN-2026; strength, dose, anatomical location and route of administration were not provided) for prophylaxis. It was reported that the suspect vaccine was underwent temperature excursions of 11 degree Fahrenheit (F)/ 6F to 14F (the time frame was 30 Minutes) (product storage error). There were no previous temperature excursions. No additional adverse event (AE) was reported (no adverse event).